Dr. Aamer H. Jamali, MD

Dr. Jamali practices at Interventional Cardiology Medical Group, Inc in West Hills, California.

Dr. Jamali's NPI, 1659309334, was assigned on June 29, 2006. Dr. Jamali graduated from David Geffen School of Medicine at UCLA in 1998. Dr. Jamali holds California license A69307.

Dr. Jamali's primary practice is Interventional Cardiology Medical Group, Inc, at 7301 N Medical Center Dr, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 702-8800.

Dr. Jamali's primary practice is Interventional Cardiology Medical Group, Inc in West Hills, California. Dr. Jamali is also affiliated with UCLA West Valley Medical Center. The medical group on file is Interventional Cardiology Medical Group. Dmand AI also links Dr. Jamali to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jamali practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Jamali's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Jamali is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Jamali is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization, pacemaker or defibrillator implantation and varicose vein treatment among the conditions Dr. Jamali treats.

CMS data shows 13,351 Medicare services from Dr. Jamali across 49 procedure codes in 2024, for 1,057 Medicare patients. Medicare paid $1,022,157 for them.

CMS counts 1,057 Medicare patients who saw Dr. Jamali in 2024. The largest group is 75 to 84, with 428 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jamali's median patient age at 74, with 48% women.

In 2024, Dr. Jamali wrote 6,136 Medicare Part D claims for 819 patients. 80% of them were for generic drugs. CMS names the drug for 5,909 of them, across 69 drugs with 11 or more claims each, at $1,202,694 in total drug cost. In 2023, CMS named 5,643 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Jamali for performance year 2024, reported as part of a group. Dr. Jamali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jamali as offering telehealth. CMS counts 23 procedures of coronary angioplasty and stenting by Dr. Jamali, more than 55% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Jamali. The most frequent topics are Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists and Blood Pressure. Dr. Jamali's most frequent co-authors are Joseph R. Aragon, MD, Saibal Kar, MD and Michael B. Fowler, MB.

CMS Open Payments shows 1,321 general payments to Dr. Jamali from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Janssen Pharmaceuticals, Inc paid the most, $160,316.

Dmand AI lists 2 awards for Dr. Jamali, most recently ACC Fellow in 2012.

Dr. Jamali graduated from David Geffen School of Medicine at UCLA in 1998. Dr. Jamali is a member of ACC.

Dr. Jamali is in network with 13 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.